I'm not sure about the timing, but if the Japan trial is successfully concluded, I can see a partnership with a Japanese pharma for Iclusig distribution in Asia. Its a large market. JMO.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.